Plaintiffs/Appellants (“Plaintiffs”) are approximately 120 shareholders of SolvEx, a now-defunct New Mexico corpora
I.
A. Statutory background
In 1995, Congress responded to perceived abuses of federal securities class action litigation by passing the Private Securities Litigation Reform Act of 1995 (“PSLRA”), Pub.L. No. 104-67, 109 Stat. 737 (1995) (codified at 15 U.S.C. §§ 77z-l, 78u~4).
See Merrill Lynch, Pierce, Fenner & Smith, Inc. v. Dabit,
[They] prompted at least some members of the plaintiffs’ bar to avoid the federal forum altogether. Rather than face the obstacles set in their path by the [PSLRA], plaintiffs and their representatives began bringing class actions under state law, often in state court. The evidence presented to Congress during a 1997 hearing to evaluate the effects of the [PSLRA] suggested that this phenomenon was a novel one; state-court litigation of class actions involving nationally traded securities had previously been rare.
Id.
at 82,
The unanticipated shift in securities class actions from federal to state court, and from federal to state law, created several problems. As the Senate Report explained:
Disparate, and shifting, state litigation procedures may expose issuers to the potential for significant liability that cannot easily be evaluated in advance, or assessed when a statement is made. At a time when we are increasingly experiencing and encouraging national and international securities offerings and listings, and expending great effort to rationalize and streamline our securities markets, this fragmentation of investor remedies potentially imposes costs that outweigh the benefits. Rather than permit or foster fragmentation of our national system of securities litigation, we should give due consideration to the benefits flowing to investors from a uniform national approach.
S.Rep. No. 105-182, at 3 (citation omitted). In addition, this shift to state court reintroduced many of the abuses that the PSLRA had attempted to mitigate, allowing plaintiffs to avoid the comparatively stringent federal pleading requirements, federal discovery stays, and other substan
Congrеss responded by passing the Securities Litigation Uniform Standards Act of 1998 (“SLUSA”), Pub.L. No. 105-353, 112 Stat. 3227 (1998). SLUSA provides for preclusion of certain securities class actions brought under state law:
(f) Limitations on remedies
(1)Class action limitations
No covered class action based upon the statutory or common law of any State or subdivision thereof may be maintained in any State or Federal court by any private party alleging'—
(A) a misrepresentation or omission of a material fact in connection with the purchase or sale of a, covered security; or
(B) that the defendant used or employed any manipulative or deceptive deviсe or contrivance in connection with the purchase or sale of a covered security.
15 U.S.C. § 78bb(f)(l);
see also Potter v. Janus Inv. Fund,
Moreover, SLUSA ■ provides federal courts with removal jurisdiction over class actions that are precluded under § 78bb(f)(l):
(2) Removal of covered class actions Any covered class action brought in any State court involving a covered security, as set forth in paragraph (1), shall be removable to the Federal district court for the district in which the action is pending, and shall be subject to paragraph (1).
15 U.S.C. § 78bb(f)(2). If, after removal, the federal court determines that SLUSA does not preclude the class action, then the federal court must remand it to state court:
(3) Preservation of certain actions—
(D) Remand of removed actions In an action that has been removed from a State court pursuant to paragraph (2), if the Federal court determines that the action may be maintained in State court pursuant to this subsection, the Federal court shall remand such action to such State court.
15 U.S.C. § 78bb(f)(3)(D). Under these provisions, the jurisdiction conferred upon the federal courts by SLUSA is, in essence, limited to determining whether 15 U.S.C. § 78bb(f)(l) precludes the plaintiffs’ claims:
Once removal jurisdiction under [15 U.S.C. § 78bb(f)(2) ] is understood to be restricted to precluded actions defined by [§ 78bb(f)(l)], a motion to remand claiming the action is not precluded must be seen as posing a jurisdictional issue. If the action is precluded, neither the District Court nor the state court may entertain it, and the proper course is to dismiss. If the action is not precluded, the federal court likewise has no jurisdiction to touch the case on the merits, and the proper course is to remand to the state court that can deal with it. In either event, ... the district court’s order comes because its adjudicatory power has been exercised and its work is done.
Kircher,
B. Procedural and factual background
Solv-Ex is a defunct New Mexico corporation whose stock was previously listed on the NASDAQ exchange. John S. Rendall, who is not a party to this action, founded Solv-Ex in 1980 to develop processes for the extraction of bitumen from oil sands. During all relevant time periods, Mr. Rendall was the chairman, CEO, and largest individual shareholder of Solv-Ex. In March 1997, Merrill Lynch made a personal loan to Mr. Rendall for $2 million. As part of the loan agreement, Mr. Rendall moved an existing $2 million margin account loan to Merrill Lynch, and he agreed to secure the $4 million in total loan amounts with 2.61 million shares of his Solv-Ex common stock, which represented more than ten percent of the issued and outstanding shares of Solv-Ex common stock. In April 1997, barely a month later, Merrill Lynch informed Mr. Rendall that it was demanding payment of the entire $4 million debt, and that it intended to sell 1.1 million of his Solv-Ex shares if he could not pay. Starting in May 1997, Merrill Lynch sold 634,100 of Mr. Rendall’s shares on the open market. During this time period, the share price of Solv-Ex common stock plunged from $13 on April 1, 1997, to slightly under $4 on June 30, 1997. In July 1997, Solv-Ex filed a petition for bankruptcy, and in September 1997, the NASDAQ de-listed its stock. 3 Solv-Ex was, and remains, dormant.
On October 24, 2006, Plaintiffs filеd the instant action against Merrill Lynch in New Mexico state court. Plaintiffs alleged that Martin Zweig and his related entities (the “Zweig Entities”) had maintained prime brokerage relationships with Merrill Lynch during the time that Mr. Rendall had pledged his shares to Merrill Lynch as security for the loans. According to Plaintiffs, the Zweig Entities engaged in short-selling of Solv-Ex stock throughout 1996 and 1997, using Merrill Lynch prime brokerage accounts, often without closing out their positions within UPC Rule 71’s ten-day closeout period. The Complaint alleged fourteen separate counts against Merrill Lynch. In Count I, Plaintiffs requested an equitable bill of discovery, permitting them to conduct depositions and compel document production in order to determine whether Merrill Lynch and/or
Merrill Lynch removed the action to the United States District Court for the District of New Mexico. As its jurisdictional bases for removal, Merrill Lynch relied upon 28 U.S.C. § 1441, as well as SLUSA, 15 U.S.C. §§ 77p(c), 78bb(f)(2). Merrill Lynch then filed a motion to dismiss under Rule 12(b)(6) of the Federal Rules of Civil Procedure, relying upon SLUSA, 15 U.S.C. § 78bb(f)(l).
On April 4, 2007, the district court granted the motion to dismiss, holding that SLUSA barred all of Plaintiffs’ claims. The district court held that Plaintiffs’ claims were a “covered class action” under SLUSA, despite Plaintiffs’ attempt to seek an equitable bill of discovery as an alternative remedy. The district court also rejected Plaintiffs’ request for leave to amend their Complaint to assert a derivative action against Merrill Lynch on behalf of Solv-Ex. The district court explained that “Plaintiffs have not attached a proposed amended complaint to their Response as is required by this District’s local rules.” Dist. Ct. Op., ROA, Vol. I, at 171 (citing D.N.M. Civ. R. 15.1). In addition, Plaintiffs did not “explain how they will be able to meet the requirements for filing an exclusively derivative action under Rule 23.1 of the Federal Rules of Civil Procedure,” or “offer any enlightenment on how they could pursue the required ‘exclusive derivative action’ on these facts.”
Id.
The district court further noted that New Mexico law does not permit a shareholder “to recover for injuries done to the corporation.”
Id.
(citing
Marchman v. NCNB Tex. Nat’l Bank,
The district court then held that SLUSA barred Plaintiffs’ claims. The district court rejected Plaintiffs’ argument that SLUSA only precluded claims having “elements identical to those required for federal securities fraud,” such as scienter. Id. at 172. The district court explained that “it is not necessary that the state law claim line up exactly with the requirements of federal securities statutes to be barred by SLUSA.” Id. Plaintiffs made several allegations in their Complaint regarding “misrepresentation[s] or omission[s] of a material fact” and “manipulative or deceptive device[s],” “in connection with the purchase or sale of a covered security,” and the district court held that this was all that SLUSA required. Id. at 173.
On appeal, Plaintiffs argue that the district court erred in determining that SLU-SA precluded their claims. Altеrnatively, they argue that the district court should have granted them leave to amend their Complaint.
II.
A. Plaintiffs ’ claims under SL USA
The district court correctly held that SLUSA precluded Plaintiffs’ claims
The seminal case on the scope of SLU-SA is the Supreme Court’s 2006 decision in
Dabit,
in which the Court concluded that SLUSA precluded claims by holders — and not just purchasers or sellers — of covered securities. The Court rejected a narrow interpretation of the statutory phrase, “in connection with the purchase or sale of a covered security,” 15 U.S.C. § 78bb(f)(l)(A), (B), despite the plaintiffs’ argument that those words incorporated the same purchaser-seller requirement into SLUSA that the Cоurt had adopted in
Blue Chip Stamps v. Manor Drug Stores,
Further, the Court in Dabit based its broad reading of SLUSA on the purpose of statute:
The presumption that Congress envisioned a broad construction follows not only from ordinary principles of statutory construction but also from the particular concerns that culminated in SLU-SA’s enactment. A narrow reading of the statute would undercut the effectiveness of the [PSLRA] and thus run contrary to SLUSA’s stated purpose, viz., to prevent certain State private securities class action lawsuits alleging fraud from being used to frustrate the objectives of the [PSLRA]. As the Blue Chip Stamps Court observed, class actions brought by holders [ (rather than just purchasers or sellers) ] pose a special risk of vexatious litigation. It would be odd, tо say the least, if SLUSA exempted that particularly troublesome subset of class actions from its pre-emptive sweep.
Id.
at 86,
carries less force here than in other contexts beсause SLUSA does not actually pre-empt any state cause of action. It simply denies plaintiffs the right to use the class action device to vindicate certain claims. The Act does not denyany individual plaintiff, or indeed any group of fewer than 50 plaintiffs, the right to enforce any state-law cause of action that may exist.
Moreover, the tailored exceptions to SLUSA’s pre-emptive command demonstrate that Congress did not by any means act “cavalierly” here. The statute carefully exempts from its operation certain class actions based on the law оf the State in which the issuer of the covered security is incorporated, actions brought by a state agency or state pension plan, actions under contracts between issuers and indenture trustees, and derivative actions brought by shareholders on behalf of a corporation. The statute also expressly preserves state jurisdiction over state agency enforcement proceedings. The existence of these carve-outs both evinces congressional sensitivity to state prerogatives in this field and makes it inappropriate for courts to create additional, implied exceptions.
Id.
at 87-88,
Plaintiffs’ argument in the instant case parallels the argument that the Supreme Court rejected in Dabit. The essence of Plaintiffs’ argument is that, because SLUSA employs language similar to that in Rule 10b-5, 4 SLUSA only precludes state law claims that are “virtually identical” to a federal securities fraud claim under 10b-5 — i.e., claims requiring plaintiffs to allege the “essential elements” of scienter and reliance. Under this standard, Plaintiffs argue, SLUSA does not preclude any of their claims under New Mexico law, because none of their claims allege — or are required to allegе — -the elements of scienter and reliance.
Plaintiffs are not unique in making this argument, and courts have almost uniformly rejected it as contrary to the structure, intent, and plain language of SLUSA. As the Eleventh Circuit has explained:
SLUSA amends both the 1933 Act (15 U.S.C. § 77p) and the 1934 Act (15 U.S.C. § 78bb), preempting claims brought under both of those statutes. The sections of SLUSA that amend the 1933 Act track the language of § § 11 and 12(a)(2), and claims under § § 11 and 12(a)(2) of the 1933 Act do not require a showing of scienter. Thus, SLUSA preempts some claims — namely, those brought under § 11 or 12(a)(2) of the 1933 Act — that lack a scienter requirement. Accordingly, we cannot accept [the plaintiffs’] contention that scienter is the dispositive factor in determining whether a given lawsuit falls within the scope of SLUSA.
Riley v. Merrill Lynch, Pierce, Fenner & Smith, Inc.,
In its
amicus
brief to the Second Circuit in
Dabit,
the SEC provided a cogent analysis of the proper scope of SLUSA, much of which is relevant here. See Brief of the SEC as
Amicus Curiae
on Issues Addressed,
Dabit v. Merrill Lynch, Pierce, Fenner & Smith, Inc.,
The imposition of a scienter requirement would also be inconsistent with SLUSA’s principal purpose.... While part of Congress’s concern was the procedural constraints on class action litigation, another concern was compelling compliance with the PSLRA’s heightened scienter pleading standard, which requires plaintiffs in Rule 10b-5 cases to allege scientеr with greater specificity than many courts had previously required. To the extent that migration toward state courts had been fueled by this requirement, it would have been because plaintiffs found it difficult, after the PSLRA, to make an adequate claim of scienter in Rule 10b-5 cases. If it were to be held that SLUSA does not apply to a case which cannot, for lack of an allegation of scienter, be brought under Rule 10b-5, this objective of SLUSA would be largely undercut. SLUSA could not compel compliance with the PSLRA’s scienter pleading standard, since it simply would not apply to any class action cоmplaint that could not comply with the PSLRA standard. Congress could not have intended such a self-defeating result.
Id. at 27-29 (citations omitted). Along these lines, the SEC also noted that “[n]othing in the language of SLUSA suggests that any of the other requirements of a private Rule 10b-5 action — such as statute of limitations, reliance, loss causation— must be met before SLUSA preemption will apply.” Id. at 29 n. 7. The SEC was quick to clarify, however, that “[t]he clear language of SLUSA ... requires that the action allege a misrepresentation or misleading omission or other deception,” so “a pure breach-of-contraet сlaim — with no allegation of misrepresentation — [does not] eome[ ] within the terms of the preemption provisions.” Id. at 24.
In light of these authorities, the district court was correct that SLUSA precluded Plaintiffs’ claims, and that Plaintiffs did not have to allege scienter or reliance for SLUSA to apply. Plaintiffs do not contest that their claims constitute a “covered class action,” that is based on state law, and that is “in connection with the purchase or sale of a covered security.” 15 U.S.C. § 78bb(f)(l). Nor do Plaintiffs’ claims fit within one of the exceptions provided under SLUSA.
See
15 U.S.C. § 78bb(f)(3)-(4). Most importantly, in their Complaint, Plaintiffs make several allegations regarding “misrepresentation[s] or omission[s] of a material fact” and/or “manipulative or deceptive device[s] or contrivance[s].”
See, e.g.,
Compl., ROA, Vol. I, at 13, ¶ 46 (“Naked short selling can present substantial manipulation concerns.”);
id.
at 15, ¶ 54 (“It is the inevitable market imbalances, the unfair leverage gained, and the largely unchecked potential for manipulation in the naked short seller-prime broker context that is at the heart of this action. And, it is the interaction between one or more major short sellers of Solv-Ex stock and their prime broker Merrill Lynch, and how those interactions caused Merrill Lynch to abruptly set in motion the events necessitating the sale of Rendall’s pledged shares, that is the necessary subject for inquiry in this action.”);
id.
at 24-25, ¶¶ 92, 94, 96-99 (contending that, on several occasions, the “Zweig Entities sold Solv-Ex shares through their Merrill Lynch prime brokerage accounts,” that “[e]ach sale was a short sale,” and that they did not later purchase Solv-Ex shares to cover these short sales, or otherwise “close[] out their short positions in Solv-Ex”);
id.
at 35, ¶ 153 (“The reasonable inferences to be drawn from the facts now known, however, are that Merrill Lynch, alone or in сoncert with other persons or parties, intentionally acted to harm Mr. Rendall and thereby the Plaintiffs.”). All of the substantive counts listed in Plaintiffs’ Complaint incorporate these allegations by reference.
6
Also, several of
The cases that Plaintiffs cite in their brief do not compel a conclusion to the contrary. For instance, in
Contreras v. Host America Corp.,
B. Denial of leave to amend the Complaint
The district court did not abuse its discretion in refusing to grant Plaintiffs leave to amend their Complaint. “We review the denial of a motion to amend for abuse of discretion.”
Anderson v. Suiters,
Any amendment by Plaintiffs here would have been futile. SLUSA precluded all of the substantive counts that Plaintiffs alleged in their Complaint, so Plaintiffs could not have saved their Complaint by withdrawing a few of the counts. Additionally, Plaintiffs have nowhere explained how they could transform their Complaint into a derivative action on behalf of SolvEx, nor did they attach a proposed amended complaint to their response filed with
Finally, plaintiffs argue the district court abused its discretion in denying them leave to file an amended complaint. Plaintiffs first raised this issue at the end of their brief to the district court on the removal and preemption issues, stating that “if defendants’ motion to dismiss is granted, plaintiffsf] should be permitted to file an amended complaint.” Plaintiffs did not include a proposed amended pleading, as Local Rule 15.1 of the Northern District of Iowa requires. Nor did plaintiffs describe what changes they would make to avoid SLUSA preemption, or what non-futile federal causes of action they would seek to assert. In these circumstances, the district court did not abuse its discretion in granting defendants’ motion to dismiss.
Dudek,
AFFIRMED.
Notes
. “A ‘covered class action’ is a lawsuit in which damages are sought on behalf of more than 50 people.”
Dabit,
. The statutory provisions cited herein are SLUSA's amendments to the Securities Exchange Act of 1934. SLUSA "amends the 1933 Act and the 1934 Act in substantially identical ways.”
Dabit,
. Plaintiffs’ Complaint describes, in detail, several of the problems that Solv-Ex faced in 1996 and 1997, including a wave of bad publicity, federal criminal investigations, and lawsuits. These details are largely irrelevant to the instant appeal, so we will not discuss them with additional specificity.
. Rule 10b-5 makes it "unlawful for any person”:
(a) To employ any device, scheme, or artifice to defraud,
(b) To make any untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading, or
(c) To engage in any act, practice, or course of business which operates or would operate as a fraud or deceit upon any person, in connection with the purchase or sale of any security.
17 C.F.R. § 240.10b-5; see also 15 U.S.C. § 78j(b) (making it “unlawful for any person ... [t]o use or employ, in connection with the purchase or sale of any security registered on a national securities exchange or any security not so registered, ... any manipulative or deceptive device or contrivance in contravention of such rules and regulations as the Commission may prescribe as necessary or appropriate in the public interest or for the protection of investors”).
. A copy of the SEC’s amicus brief to the Second Circuit is available at http://www.sec. gov/litigation/briefs/dabit062204.pdf.
. A few courts have held that, because SLUSA uses the word "action,” SLUSA requires dismissing the entire class action complaint if one or more of the individual claims is precluded by SLUSA.
See, e.g., In re Lord Abbett Mnt. Funds Fee Litig.,
. Because the district court did not abuse its discretion here, we need not decide whether the provisions of SLUSA, by themselves, prohibit Plaintiffs from amending their Complaint.
See U.S. Mortgage, Inc. v. Saxton,